Branch retinal vein occlusion (BRVO) is a common retinal vascular disease, but global protein changes following the condition remain largely unelucidated. To bring new insights into pathological processes and identify potential therapeutic targets, large-scale retinal protein changes following BRVO were studied by combining a porcine model of experimental BRVO with proteomic analysis by label-free liquid chromatography mass spectrometry. Among a total set of 1974 proteins, 52 significantly upregulated proteins and 10 significantly downregulated proteins were identified in retinas with BRVO after 15 days. Significantly upregulated proteins were involved in signaling pathways of focal adhesion via integrin and blood coagulation. Proteins invo...
Retinal ischemia occurs in a variety of eye diseases. Restrained blood flow induces retinal damage, ...
Background Central retinal vein occlusion (CRVO) is a common disease characterized by a disrupted re...
Retinal vein occlusion (RVO) is a frequent visually disabling condition. The management of RVO conti...
Retinal vein occlusion (RVO) is a common retinal vascular disease. RVO may be complicated by pronoun...
Background: The pathophysiological mechanisms of macular edema secondary to branch retinal vein ...
Central retinal vein occlusion (CRVO) is a common disease characterized by a disrupted retinal blood...
Central retinal vein occlusion (CRVO) is a common disease characterized by a disrupted retinal blood...
Bevacizumab is a frequently used inhibitor of vascular endothelial growth factor (VEGF) in the manag...
Branch retinal vein occlusion induces complex biological processes in the retina that are generated ...
Retinal vascular hyperpermeability causes macular edema, leading to visual deterioration in retinal ...
Aflibercept is an inhibitor of vascular endothelial growth factor (VEGF) used to treat macular edema...
Retinal artery occlusion (RAO), retinal vein occlusion (RVO), diabetic retinopathy (DR) and age-rela...
Tear samples collected from patients with central retinal vein occlusion (CRVO; n = 28) and healthy ...
Aflibercept is a frequently used inhibitor of vascular endothelial growth factor (VEGF) in the treat...
ABSTRACT Adhesive interactions between integrin receptors and the extracellular matrix (ECM) are int...
Retinal ischemia occurs in a variety of eye diseases. Restrained blood flow induces retinal damage, ...
Background Central retinal vein occlusion (CRVO) is a common disease characterized by a disrupted re...
Retinal vein occlusion (RVO) is a frequent visually disabling condition. The management of RVO conti...
Retinal vein occlusion (RVO) is a common retinal vascular disease. RVO may be complicated by pronoun...
Background: The pathophysiological mechanisms of macular edema secondary to branch retinal vein ...
Central retinal vein occlusion (CRVO) is a common disease characterized by a disrupted retinal blood...
Central retinal vein occlusion (CRVO) is a common disease characterized by a disrupted retinal blood...
Bevacizumab is a frequently used inhibitor of vascular endothelial growth factor (VEGF) in the manag...
Branch retinal vein occlusion induces complex biological processes in the retina that are generated ...
Retinal vascular hyperpermeability causes macular edema, leading to visual deterioration in retinal ...
Aflibercept is an inhibitor of vascular endothelial growth factor (VEGF) used to treat macular edema...
Retinal artery occlusion (RAO), retinal vein occlusion (RVO), diabetic retinopathy (DR) and age-rela...
Tear samples collected from patients with central retinal vein occlusion (CRVO; n = 28) and healthy ...
Aflibercept is a frequently used inhibitor of vascular endothelial growth factor (VEGF) in the treat...
ABSTRACT Adhesive interactions between integrin receptors and the extracellular matrix (ECM) are int...
Retinal ischemia occurs in a variety of eye diseases. Restrained blood flow induces retinal damage, ...
Background Central retinal vein occlusion (CRVO) is a common disease characterized by a disrupted re...
Retinal vein occlusion (RVO) is a frequent visually disabling condition. The management of RVO conti...